Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Breast cancer vaccines are still experimental, with no FDA‑approved vaccines yet, but early phase I trials — especially for triple‑negative breast cancer — show promising immune responses in most participants.
Breast cancer vaccines are still experimental, with no FDA‑approved vaccines yet, but early phase I trials — especially for triple‑negative breast cancer — show promising immune responses in most participants.